Working with mouse models and human cancer cells, the researchers identified a metabolic enzyme called GUK1 in lung cancers ...

Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, and it can shapeshift in unpredictable ways to evade treatment.

Former public defender Denise Lee is spreading the word about a lung scan that saved her life — and she learned about it from ...

Using ALK+ lung cancer patient-derived cell lines, researchers have performed phosphoproteomic screening and identified guanylate kinase 1 (GUK1) as a TKI sensitive metabolic molecule in ALK-driven ...

Roche's Alecensa has been recommended for routine NHS use as an adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC), the first targeted therapy for this indication. Alecensa ...

Lung cancer, one of the four most common types of cancer in the UK, sees over 49,000 new cases each year, according to Cancer Research UK. This disease is triggered by an uncontrolled growth of ...

Lung cancer screening aims to find lung cancer early. This is when there are more treatment options available and there is the best chance of treating it successfully. In the UK, the National ...

Madan Gopal, Senior Public Health Expert, National Health Systems Resource Center; Dr. Urvashi Prasad, Living with ALK + Lung Cancer, Public Health & Policy Specialist and Dr. Chitra Gupta ...

New Screening Device Shows Promise for Early Lung Cancer Detection Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way ...

Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...

Your healthcare team might also call them lung neuroendocrine neoplasms (lung NENs). But this means the same as lung neuroendocrine cancer. There are neuroendocrine cells in most organs of our body, ...